Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study

Chengyu Liu,Zikang Li,Zhilei Zhang,Jinlong Li,Congxi Xu,Yuming Jia,Chong Zhang,Wuhan Yang,Wenchuan Wang,Xiaojuan Wang,Kuopeng Liang,Li Peng,Jitao Wang
DOI: https://doi.org/10.1186/s12876-024-03185-z
2024-03-05
BMC Gastroenterology
Abstract:Hepatocellular carcinoma (HCC) has a poor prognosis, and alpha-fetoprotein (AFP) is widely used to evaluate HCC. However, the proportion of AFP-negative individuals cannot be disregarded. This study aimed to establish a nomogram of risk factors affecting the prognosis of patients with AFP-negative HCC and to evaluate its diagnostic efficiency.
gastroenterology & hepatology
What problem does this paper attempt to address?